Adverse events (machine tolerability outcomes) · adults with a diagnosis of OSA
1 finding from 1 review
Machine usage Hours per night · adults with a diagnosis of sleep apnoea
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Postoperative opioid consumption, 'overall' (MEQ, mg) · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Gastrointestinal recovery · adults undergoing surgery with general anaesthesia
It is very uncertain whether intravenous (IV) lidocaine changes gastrointestinal recovery compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Adverse events (e.g. the number of participants that died, or had arrhythmias, other heart rate disorders, or showed any signs of lidocaine toxicity) · adults undergoing surgery with general anaesthesia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Nausea · adults undergoing surgery with general anaesthesia
It is very uncertain whether intravenous (IV) lidocaine changes postoperative nausea, 'overall' (0 to 24 h, to 48 h, to 72 h) compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Postoperative opioid consumption, 'overall' (MEQ, mg) · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Gastrointestinal recovery · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Adverse events (e.g. the number of participants that died, or had arrhythmias, other heart rate disorders, or showed any signs of lidocaine toxicity) · adults undergoing surgery with general anaesthesia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Nausea · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Intervention not reported
All‐cause mortality · CKD patients (any stage) treated for anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Epoetin · CKD patients (any stage) treated for anaemia
1 finding from 1 review
Intervention not reported
Darbepoetin · CKD patients (any stage) treated for anaemia
1 finding from 1 review
Intervention not reported
CERA Q4W · CKD patients (any stage) treated for anaemia
1 finding from 1 review
Intervention not reported
CERA higher dose · CKD patients (any stage) treated for anaemia
1 finding from 1 review
Intervention not reported
Hypertension · CKD patients (any stage) treated for anaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
PLACEBO · CKD patients (any stage) treated for anaemia
1 finding from 1 review
Hypertensive disorders of pregnancy · pregnant women with diabetes
1 finding from 1 review